Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Naprosyn SR |
Active Ingredient: | Naproxen 750mg |
Dosage Form: | Modified release tablet |
New Zealand Sponsor: | Clinect NZ Pty Limited |
Manufacturer: | Recipharm Leganes S.L.U., Leganes, Spain |
Product: | Naprosyn SR |
Active Ingredient: | Naproxen 1000mg |
Dosage Form: | Modified release tablet |
New Zealand Sponsor: | Clinect NZ Pty Limited |
Manufacturer: | Recipharm Leganes S.L.U., Leganes, Spain |
Product: | Priorix-Tetra |
Active Ingredients: | Measles vaccine, Schwarz strain 1000CCID50 Mumps virus, live attenuated, RIT 4385 25119CCID50 Rubella virus, Wistar RA27/3 strain 1000CCID50 Varicella vaccine 1995PFU |
Dosage Form: | Powder for injection with diluent |
New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
Manufacturers: | GlaxoSmithKline Biologicals SA, Rixensart, Belgium GlaxoSmithKline Biologicals SA, Wavre, Belgium |
Product: | Varilrix Vaccine |
Active Ingredient: | Varicella vaccine 2000PFU |
Dosage Form: | Powder for injection with diluent |
New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
Manufacturers: | Fidia Farmaceutici SpA, Abano Terme, Italy Corixa Corporation dba GlaxoSmithKline Vaccines, Pennsylvania, United States of America |
Dated this 20th day of February 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).